In 2023, European VC investments continue to decline for now half a year with 410 investments in February.<\/h3>\n<\/div>\n<\/div>\n
[\/vc_column_text][vc_column_text el_id=”total”]<\/p>\n
Number and amounts of announced funding rounds over the past 6 months*<\/b><\/h4>\n
[\/vc_column_text][vc_single_image image=”2299″ img_size=”large” alignment=”center” style=”vc_box_shadow”][vc_column_text]<\/p>\n
* All data from crunchbase, as of March 6th, 2023<\/h6>\n<\/div>\n<\/div>\n
[\/vc_column_text][vc_column_text css=”.vc_custom_1690991860911{margin-top: 60px !important;}” el_id=”industry”]<\/p>\n
Software startups are once again the most popular investments<\/b><\/h3>\n\n- During the month of\u00a0February, 410 financing rounds were announced.<\/b><\/li>\n
- The\u00a0total amount invested\u00a0<\/b>in the announced financing rounds\u00a0decreased to $2.7bn\u00a0<\/b>from $3.4bn in January.<\/li>\n
- Once again, most investments were made in\u00a0Software companies, amounting to 106 investments<\/b>, followed by information technology (61).\u00a0In February, investments in AI companies make up the third place (41).<\/b><\/li>\n
- <\/li>\n<\/ul>\n
[\/vc_column_text][vc_column_text el_id=”top10″]<\/p>\n
\n\nTop 10 industries of financed startups according to the number of conducted investments<\/h4>\n<\/div>\n<\/div>\n
[\/vc_column_text][vc_single_image image=”2300″ img_size=”400×560″ alignment=”center” style=”vc_box_shadow”][vc_column_text el_id=”investors”]<\/p>\n
\n\nAntler is the most active investor of February; 164 seed rounds were conducted<\/h3>\n<\/div>\n<\/div>\n
[\/vc_column_text][vc_column_text el_id=”highest”]<\/p>\n
\n\nInvestors with the highest number of investments in February<\/h4>\n<\/div>\n<\/div>\n
[\/vc_column_text][vc_single_image image=”2301″ img_size=”large” alignment=”center”][vc_column_text el_id=”rounds”]<\/p>\n
\n\nNumber and total volume of financing rounds per stage<\/h4>\n<\/div>\n<\/div>\n
[\/vc_column_text][vc_single_image image=”2293″ img_size=”large” alignment=”center”][vc_column_text css=”.vc_custom_1690991939948{margin-top: 60px !important;}” el_id=”largest”]<\/p>\n
Largest round was a Series B Round of $135.0mn<\/h3>\n\n\nIn February,\u00a0most investments\u00a0<\/b>rounds were\u00a0Seed Rounds.\u00a0<\/b>Despite that, the\u00a0largest volume of invested money was in 56 Series A Rounds\u00a0<\/b>($712.1mn).<\/p>\n<\/div>\n<\/div>\n
[\/vc_column_text][vc_single_image image=”2294″ img_size=”large” alignment=”center” style=”vc_box_shadow”][vc_column_text css=”.vc_custom_1690991961182{margin-top: 60px !important;}” el_id=”hotspot”]<\/p>\n
London, UK, is once again the European startup hotspot of the month<\/h3>\n\n- Not only were the\u00a0most investments conducted in the UK\u00a0<\/b>(#117), but the\u00a0highest volume was also invested there\u00a0<\/b>during February ($964.6mn).<\/li>\n
- When ranking by invested volume instead of number of investments,\u00a0Copenhagen ($144.7) takes the third place for cities and Denmark ($193.7) fourth place for countries.<\/b><\/li>\n<\/ul>\n
[\/vc_column_text][vc_single_image image=”2295″ img_size=”large” alignment=”center” style=”vc_box_shadow”][vc_column_text el_class=”Spotlight” el_id=”spotlight”]<\/p>\n
\n\nIn the spotlight: hemab raised $135mn in February with the help of 9 investors<\/h3>\n<\/div>\n<\/div>\n
[\/vc_column_text][vc_row_inner][vc_column_inner width=”1\/3″][vc_column_text]<\/p>\n
Company<\/h3>\n
[\/vc_column_text][vc_single_image image=”2297″ img_size=”medium”][vc_column_text]<\/p>\n
Industry<\/h5>\n
Biotech\/Pharmaceutical<\/p>\n
Founded in<\/h5>\n
2017, Copenhagen<\/p>\n
One-Sentence-Pitch<\/h5>\n
Hemab is a clinical-stage biotech company developing prophylactic therapeutics for serious, underserved bleeding and thrombotic disorders.[\/vc_column_text][\/vc_column_inner][vc_column_inner width=”1\/3″][vc_column_text]<\/p>\n
Financing round<\/b><\/h3>\n
[\/vc_column_text][vc_column_text]<\/p>\n
Money raised<\/h5>\n
$135mn<\/p>\n
Company valuation<\/h5>\n
Series B<\/p>\n
Type of financing round<\/h5>\n
Series B<\/p>\n
Comment\/Quote<\/h5>\n
The financing will support Hemab\u2019s scientific and corporate growth plans through 2025, including completion of two Phase 1\/2 clinical studies, initiation of pivotal studies and future pipeline evolution. (BioSpace.com)[\/vc_column_text][\/vc_column_inner][vc_column_inner width=”1\/3″][vc_column_text]<\/p>\n
Investors<\/h3>\n
[\/vc_column_text][vc_single_image image=”2296″ img_size=”full” alignment=”center”][\/vc_column_inner][\/vc_row_inner][vc_column_text]Falls Sie mehr \u00fcber Risikokapitalfinanzierung erfahren m\u00f6chten, sollten Sie unseren umfassenden Ratgeber zu diesem Thema lesen: Risikokapitalfinanzierung: Ein Leitfaden f\u00fcr Anf\u00e4nger<\/p>\n
Trustventure ber\u00e4t junge Unternehmen zu Herausforderung im Finanzbereich und bietet CFO-As-A-Service-Leistungen an. Die Expertise in Fragen zur Unternehmensfinanzierung, Planung und zum Controlling schafft Transparenz und Sicherheit f\u00fcr Sie und Ihre Investoren. Melden Sie sich gerne \u00fcber unser Kontaktformular oder schreiben Sie uns direkt an office@trustventure.de<\/a>.[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"With 410 investments, February continues following the decline of European VC investments. In our exploration of this month’s landscape, we illuminate the current trends, noteworthy investments, and key personalities shaping the dynamic entrepreneurial environment.","protected":false},"author":2,"featured_media":2298,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[185],"tags":[],"post_folder":[],"class_list":["post-2846","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-vc-landscape-en"],"acf":[],"_links":{"self":[{"href":"https:\/\/dev.jbraucker.com\/trustventure\/wp-json\/wp\/v2\/posts\/2846","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dev.jbraucker.com\/trustventure\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dev.jbraucker.com\/trustventure\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dev.jbraucker.com\/trustventure\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/dev.jbraucker.com\/trustventure\/wp-json\/wp\/v2\/comments?post=2846"}],"version-history":[{"count":4,"href":"https:\/\/dev.jbraucker.com\/trustventure\/wp-json\/wp\/v2\/posts\/2846\/revisions"}],"predecessor-version":[{"id":3051,"href":"https:\/\/dev.jbraucker.com\/trustventure\/wp-json\/wp\/v2\/posts\/2846\/revisions\/3051"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dev.jbraucker.com\/trustventure\/wp-json\/wp\/v2\/media\/2298"}],"wp:attachment":[{"href":"https:\/\/dev.jbraucker.com\/trustventure\/wp-json\/wp\/v2\/media?parent=2846"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dev.jbraucker.com\/trustventure\/wp-json\/wp\/v2\/categories?post=2846"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dev.jbraucker.com\/trustventure\/wp-json\/wp\/v2\/tags?post=2846"},{"taxonomy":"post_folder","embeddable":true,"href":"https:\/\/dev.jbraucker.com\/trustventure\/wp-json\/wp\/v2\/post_folder?post=2846"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
[\/vc_column_text][vc_column_text el_id=”top10″]<\/p>\n
Top 10 industries of financed startups according to the number of conducted investments<\/h4>\n<\/div>\n<\/div>\n
[\/vc_column_text][vc_single_image image=”2300″ img_size=”400×560″ alignment=”center” style=”vc_box_shadow”][vc_column_text el_id=”investors”]<\/p>\n
Antler is the most active investor of February; 164 seed rounds were conducted<\/h3>\n<\/div>\n<\/div>\n
[\/vc_column_text][vc_column_text el_id=”highest”]<\/p>\n
Investors with the highest number of investments in February<\/h4>\n<\/div>\n<\/div>\n
[\/vc_column_text][vc_single_image image=”2301″ img_size=”large” alignment=”center”][vc_column_text el_id=”rounds”]<\/p>\n
Number and total volume of financing rounds per stage<\/h4>\n<\/div>\n<\/div>\n
[\/vc_column_text][vc_single_image image=”2293″ img_size=”large” alignment=”center”][vc_column_text css=”.vc_custom_1690991939948{margin-top: 60px !important;}” el_id=”largest”]<\/p>\n
Largest round was a Series B Round of $135.0mn<\/h3>\n\n\nIn February,\u00a0most investments\u00a0<\/b>rounds were\u00a0Seed Rounds.\u00a0<\/b>Despite that, the\u00a0largest volume of invested money was in 56 Series A Rounds\u00a0<\/b>($712.1mn).<\/p>\n<\/div>\n<\/div>\n
[\/vc_column_text][vc_single_image image=”2294″ img_size=”large” alignment=”center” style=”vc_box_shadow”][vc_column_text css=”.vc_custom_1690991961182{margin-top: 60px !important;}” el_id=”hotspot”]<\/p>\n
London, UK, is once again the European startup hotspot of the month<\/h3>\n\n- Not only were the\u00a0most investments conducted in the UK\u00a0<\/b>(#117), but the\u00a0highest volume was also invested there\u00a0<\/b>during February ($964.6mn).<\/li>\n
- When ranking by invested volume instead of number of investments,\u00a0Copenhagen ($144.7) takes the third place for cities and Denmark ($193.7) fourth place for countries.<\/b><\/li>\n<\/ul>\n
[\/vc_column_text][vc_single_image image=”2295″ img_size=”large” alignment=”center” style=”vc_box_shadow”][vc_column_text el_class=”Spotlight” el_id=”spotlight”]<\/p>\n
\n\nIn the spotlight: hemab raised $135mn in February with the help of 9 investors<\/h3>\n<\/div>\n<\/div>\n
[\/vc_column_text][vc_row_inner][vc_column_inner width=”1\/3″][vc_column_text]<\/p>\n
Company<\/h3>\n
[\/vc_column_text][vc_single_image image=”2297″ img_size=”medium”][vc_column_text]<\/p>\n
Industry<\/h5>\n
Biotech\/Pharmaceutical<\/p>\n
Founded in<\/h5>\n
2017, Copenhagen<\/p>\n
One-Sentence-Pitch<\/h5>\n
Hemab is a clinical-stage biotech company developing prophylactic therapeutics for serious, underserved bleeding and thrombotic disorders.[\/vc_column_text][\/vc_column_inner][vc_column_inner width=”1\/3″][vc_column_text]<\/p>\n
Financing round<\/b><\/h3>\n
[\/vc_column_text][vc_column_text]<\/p>\n
Money raised<\/h5>\n
$135mn<\/p>\n
Company valuation<\/h5>\n
Series B<\/p>\n
Type of financing round<\/h5>\n
Series B<\/p>\n
Comment\/Quote<\/h5>\n
The financing will support Hemab\u2019s scientific and corporate growth plans through 2025, including completion of two Phase 1\/2 clinical studies, initiation of pivotal studies and future pipeline evolution. (BioSpace.com)[\/vc_column_text][\/vc_column_inner][vc_column_inner width=”1\/3″][vc_column_text]<\/p>\n
Investors<\/h3>\n
[\/vc_column_text][vc_single_image image=”2296″ img_size=”full” alignment=”center”][\/vc_column_inner][\/vc_row_inner][vc_column_text]Falls Sie mehr \u00fcber Risikokapitalfinanzierung erfahren m\u00f6chten, sollten Sie unseren umfassenden Ratgeber zu diesem Thema lesen: Risikokapitalfinanzierung: Ein Leitfaden f\u00fcr Anf\u00e4nger<\/p>\n
Trustventure ber\u00e4t junge Unternehmen zu Herausforderung im Finanzbereich und bietet CFO-As-A-Service-Leistungen an. Die Expertise in Fragen zur Unternehmensfinanzierung, Planung und zum Controlling schafft Transparenz und Sicherheit f\u00fcr Sie und Ihre Investoren. Melden Sie sich gerne \u00fcber unser Kontaktformular oder schreiben Sie uns direkt an office@trustventure.de<\/a>.[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"With 410 investments, February continues following the decline of European VC investments. In our exploration of this month’s landscape, we illuminate the current trends, noteworthy investments, and key personalities shaping the dynamic entrepreneurial environment.","protected":false},"author":2,"featured_media":2298,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[185],"tags":[],"post_folder":[],"class_list":["post-2846","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-vc-landscape-en"],"acf":[],"_links":{"self":[{"href":"https:\/\/dev.jbraucker.com\/trustventure\/wp-json\/wp\/v2\/posts\/2846","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dev.jbraucker.com\/trustventure\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dev.jbraucker.com\/trustventure\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dev.jbraucker.com\/trustventure\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/dev.jbraucker.com\/trustventure\/wp-json\/wp\/v2\/comments?post=2846"}],"version-history":[{"count":4,"href":"https:\/\/dev.jbraucker.com\/trustventure\/wp-json\/wp\/v2\/posts\/2846\/revisions"}],"predecessor-version":[{"id":3051,"href":"https:\/\/dev.jbraucker.com\/trustventure\/wp-json\/wp\/v2\/posts\/2846\/revisions\/3051"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dev.jbraucker.com\/trustventure\/wp-json\/wp\/v2\/media\/2298"}],"wp:attachment":[{"href":"https:\/\/dev.jbraucker.com\/trustventure\/wp-json\/wp\/v2\/media?parent=2846"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dev.jbraucker.com\/trustventure\/wp-json\/wp\/v2\/categories?post=2846"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dev.jbraucker.com\/trustventure\/wp-json\/wp\/v2\/tags?post=2846"},{"taxonomy":"post_folder","embeddable":true,"href":"https:\/\/dev.jbraucker.com\/trustventure\/wp-json\/wp\/v2\/post_folder?post=2846"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
In February,\u00a0most investments\u00a0<\/b>rounds were\u00a0Seed Rounds.\u00a0<\/b>Despite that, the\u00a0largest volume of invested money was in 56 Series A Rounds\u00a0<\/b>($712.1mn).<\/p>\n<\/div>\n<\/div>\n
[\/vc_column_text][vc_single_image image=”2294″ img_size=”large” alignment=”center” style=”vc_box_shadow”][vc_column_text css=”.vc_custom_1690991961182{margin-top: 60px !important;}” el_id=”hotspot”]<\/p>\n
London, UK, is once again the European startup hotspot of the month<\/h3>\n\n- Not only were the\u00a0most investments conducted in the UK\u00a0<\/b>(#117), but the\u00a0highest volume was also invested there\u00a0<\/b>during February ($964.6mn).<\/li>\n
- When ranking by invested volume instead of number of investments,\u00a0Copenhagen ($144.7) takes the third place for cities and Denmark ($193.7) fourth place for countries.<\/b><\/li>\n<\/ul>\n
[\/vc_column_text][vc_single_image image=”2295″ img_size=”large” alignment=”center” style=”vc_box_shadow”][vc_column_text el_class=”Spotlight” el_id=”spotlight”]<\/p>\n
\n\nIn the spotlight: hemab raised $135mn in February with the help of 9 investors<\/h3>\n<\/div>\n<\/div>\n
[\/vc_column_text][vc_row_inner][vc_column_inner width=”1\/3″][vc_column_text]<\/p>\n
Company<\/h3>\n
[\/vc_column_text][vc_single_image image=”2297″ img_size=”medium”][vc_column_text]<\/p>\n
Industry<\/h5>\n
Biotech\/Pharmaceutical<\/p>\n
Founded in<\/h5>\n
2017, Copenhagen<\/p>\n
One-Sentence-Pitch<\/h5>\n
Hemab is a clinical-stage biotech company developing prophylactic therapeutics for serious, underserved bleeding and thrombotic disorders.[\/vc_column_text][\/vc_column_inner][vc_column_inner width=”1\/3″][vc_column_text]<\/p>\n
Financing round<\/b><\/h3>\n
[\/vc_column_text][vc_column_text]<\/p>\n
Money raised<\/h5>\n
$135mn<\/p>\n
Company valuation<\/h5>\n
Series B<\/p>\n
Type of financing round<\/h5>\n
Series B<\/p>\n
Comment\/Quote<\/h5>\n
The financing will support Hemab\u2019s scientific and corporate growth plans through 2025, including completion of two Phase 1\/2 clinical studies, initiation of pivotal studies and future pipeline evolution. (BioSpace.com)[\/vc_column_text][\/vc_column_inner][vc_column_inner width=”1\/3″][vc_column_text]<\/p>\n
Investors<\/h3>\n
[\/vc_column_text][vc_single_image image=”2296″ img_size=”full” alignment=”center”][\/vc_column_inner][\/vc_row_inner][vc_column_text]Falls Sie mehr \u00fcber Risikokapitalfinanzierung erfahren m\u00f6chten, sollten Sie unseren umfassenden Ratgeber zu diesem Thema lesen: Risikokapitalfinanzierung: Ein Leitfaden f\u00fcr Anf\u00e4nger<\/p>\n
Trustventure ber\u00e4t junge Unternehmen zu Herausforderung im Finanzbereich und bietet CFO-As-A-Service-Leistungen an. Die Expertise in Fragen zur Unternehmensfinanzierung, Planung und zum Controlling schafft Transparenz und Sicherheit f\u00fcr Sie und Ihre Investoren. Melden Sie sich gerne \u00fcber unser Kontaktformular oder schreiben Sie uns direkt an office@trustventure.de<\/a>.[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"With 410 investments, February continues following the decline of European VC investments. In our exploration of this month’s landscape, we illuminate the current trends, noteworthy investments, and key personalities shaping the dynamic entrepreneurial environment.","protected":false},"author":2,"featured_media":2298,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[185],"tags":[],"post_folder":[],"class_list":["post-2846","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-vc-landscape-en"],"acf":[],"_links":{"self":[{"href":"https:\/\/dev.jbraucker.com\/trustventure\/wp-json\/wp\/v2\/posts\/2846","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dev.jbraucker.com\/trustventure\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dev.jbraucker.com\/trustventure\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dev.jbraucker.com\/trustventure\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/dev.jbraucker.com\/trustventure\/wp-json\/wp\/v2\/comments?post=2846"}],"version-history":[{"count":4,"href":"https:\/\/dev.jbraucker.com\/trustventure\/wp-json\/wp\/v2\/posts\/2846\/revisions"}],"predecessor-version":[{"id":3051,"href":"https:\/\/dev.jbraucker.com\/trustventure\/wp-json\/wp\/v2\/posts\/2846\/revisions\/3051"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dev.jbraucker.com\/trustventure\/wp-json\/wp\/v2\/media\/2298"}],"wp:attachment":[{"href":"https:\/\/dev.jbraucker.com\/trustventure\/wp-json\/wp\/v2\/media?parent=2846"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dev.jbraucker.com\/trustventure\/wp-json\/wp\/v2\/categories?post=2846"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dev.jbraucker.com\/trustventure\/wp-json\/wp\/v2\/tags?post=2846"},{"taxonomy":"post_folder","embeddable":true,"href":"https:\/\/dev.jbraucker.com\/trustventure\/wp-json\/wp\/v2\/post_folder?post=2846"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
[\/vc_column_text][vc_single_image image=”2295″ img_size=”large” alignment=”center” style=”vc_box_shadow”][vc_column_text el_class=”Spotlight” el_id=”spotlight”]<\/p>\n
In the spotlight: hemab raised $135mn in February with the help of 9 investors<\/h3>\n<\/div>\n<\/div>\n
[\/vc_column_text][vc_row_inner][vc_column_inner width=”1\/3″][vc_column_text]<\/p>\n
Company<\/h3>\n
[\/vc_column_text][vc_single_image image=”2297″ img_size=”medium”][vc_column_text]<\/p>\n
Industry<\/h5>\n
Biotech\/Pharmaceutical<\/p>\n
Founded in<\/h5>\n
2017, Copenhagen<\/p>\n
One-Sentence-Pitch<\/h5>\n
Hemab is a clinical-stage biotech company developing prophylactic therapeutics for serious, underserved bleeding and thrombotic disorders.[\/vc_column_text][\/vc_column_inner][vc_column_inner width=”1\/3″][vc_column_text]<\/p>\n
Financing round<\/b><\/h3>\n
[\/vc_column_text][vc_column_text]<\/p>\n
Money raised<\/h5>\n
$135mn<\/p>\n
Company valuation<\/h5>\n
Series B<\/p>\n
Type of financing round<\/h5>\n
Series B<\/p>\n
Comment\/Quote<\/h5>\n
The financing will support Hemab\u2019s scientific and corporate growth plans through 2025, including completion of two Phase 1\/2 clinical studies, initiation of pivotal studies and future pipeline evolution. (BioSpace.com)[\/vc_column_text][\/vc_column_inner][vc_column_inner width=”1\/3″][vc_column_text]<\/p>\n
Investors<\/h3>\n
[\/vc_column_text][vc_single_image image=”2296″ img_size=”full” alignment=”center”][\/vc_column_inner][\/vc_row_inner][vc_column_text]Falls Sie mehr \u00fcber Risikokapitalfinanzierung erfahren m\u00f6chten, sollten Sie unseren umfassenden Ratgeber zu diesem Thema lesen: Risikokapitalfinanzierung: Ein Leitfaden f\u00fcr Anf\u00e4nger<\/p>\n
Trustventure ber\u00e4t junge Unternehmen zu Herausforderung im Finanzbereich und bietet CFO-As-A-Service-Leistungen an. Die Expertise in Fragen zur Unternehmensfinanzierung, Planung und zum Controlling schafft Transparenz und Sicherheit f\u00fcr Sie und Ihre Investoren. Melden Sie sich gerne \u00fcber unser Kontaktformular oder schreiben Sie uns direkt an office@trustventure.de<\/a>.[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"With 410 investments, February continues following the decline of European VC investments. In our exploration of this month’s landscape, we illuminate the current trends, noteworthy investments, and key personalities shaping the dynamic entrepreneurial environment.","protected":false},"author":2,"featured_media":2298,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[185],"tags":[],"post_folder":[],"class_list":["post-2846","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-vc-landscape-en"],"acf":[],"_links":{"self":[{"href":"https:\/\/dev.jbraucker.com\/trustventure\/wp-json\/wp\/v2\/posts\/2846","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dev.jbraucker.com\/trustventure\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dev.jbraucker.com\/trustventure\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dev.jbraucker.com\/trustventure\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/dev.jbraucker.com\/trustventure\/wp-json\/wp\/v2\/comments?post=2846"}],"version-history":[{"count":4,"href":"https:\/\/dev.jbraucker.com\/trustventure\/wp-json\/wp\/v2\/posts\/2846\/revisions"}],"predecessor-version":[{"id":3051,"href":"https:\/\/dev.jbraucker.com\/trustventure\/wp-json\/wp\/v2\/posts\/2846\/revisions\/3051"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dev.jbraucker.com\/trustventure\/wp-json\/wp\/v2\/media\/2298"}],"wp:attachment":[{"href":"https:\/\/dev.jbraucker.com\/trustventure\/wp-json\/wp\/v2\/media?parent=2846"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dev.jbraucker.com\/trustventure\/wp-json\/wp\/v2\/categories?post=2846"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dev.jbraucker.com\/trustventure\/wp-json\/wp\/v2\/tags?post=2846"},{"taxonomy":"post_folder","embeddable":true,"href":"https:\/\/dev.jbraucker.com\/trustventure\/wp-json\/wp\/v2\/post_folder?post=2846"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}